Benjamin Renkosinski
Papers
1
Total Citations
14
H-Index
1
About
Benjamin Renkosinski is a leading voice in gynecologic oncology, with a focused expertise in surgical innovation and cost-effectiveness for high-risk patient populations. His work critically addresses the intersection of advanced surgical technology and health equity, particularly for women with Class III obesity or higher undergoing treatment for endometrial cancer. Renkosinski’s most cited study, a 2021 prospective comparison of costs between robotics, laparoscopy, and laparotomy, is a landmark contribution that provides the first rigorous, multi-center cost analysis for this specific demographic. By demonstrating that robotic surgery, while more expensive in the operating room, can reduce inpatient and overall costs through shorter hospital stays and fewer complications, his research directly informs clinical decision-making and hospital resource allocation. This work has garnered 14 citations, reflecting its immediate impact on surgical protocols and health policy discussions. Renkosinski’s commitment to evidence-based practice and patient-centered outcomes makes him a pivotal figure in advancing surgical care for women with complex medical needs, ensuring that cost considerations do not compromise the quality of oncologic treatment.
Research Focus
Key Achievements
Top Papers
- 1